Evidence map›Paper›PMID 30462646›Full record

ArticlePloS one2018

Salivary immunity and lower respiratory tract infections in non-elite marathon runners.

Elisabet Cantó, Emma Roca, Lidia Perea, Ana Rodrigo-Troyano, Guillermo Suarez-Cuartin, Jordi Giner, Anna Feliu, Jose Manuel Soria, Lexa Nescolarde, Silvia Vidal and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Elisabet CantóExperimental Immunology, Institut de Recerca, Hospital Sant Pau, Barcelona, Spain.
Emma RocaUniversitat Politècnica de Catalunya, Barcelona, Spain.
Lidia PereaExperimental Immunology, Institut de Recerca, Hospital Sant Pau, Barcelona, Spain.
Ana Rodrigo-TroyanoBiomedical Research Insitute Sant Pau (IIB-Sant Pau), Barcelona, Spain.
Guillermo Suarez-CuartinBiomedical Research Insitute Sant Pau (IIB-Sant Pau), Barcelona, Spain.ORCID 0000-0003-2320-6047
Jordi GinerBiomedical Research Insitute Sant Pau (IIB-Sant Pau), Barcelona, Spain.
Anna FeliuBiomedical Research Insitute Sant Pau (IIB-Sant Pau), Barcelona, Spain.
Jose Manuel SoriaBiomedical Research Insitute Sant Pau (IIB-Sant Pau), Barcelona, Spain.
Lexa NescolardeUniversitat Politècnica de Catalunya, Barcelona, Spain.
Silvia VidalExperimental Immunology, Institut de Recerca, Hospital Sant Pau, Barcelona, Spain.
Oriol SibilaBiomedical Research Insitute Sant Pau (IIB-Sant Pau), Barcelona, Spain.ORCID 0000-0002-4833-6713
Universitat Autònoma de Barcelona · ESHospital de Sant Pau · ESUniversitat Politècnica de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleRespiratory infections are common after strenuous exercise, when salivary immunity may be altered. We aim to investigate changes in salivary immunity after a marathon and its relationship with lower respiratory tract infections (LRTI) in healthy non-elite marathon runners.

methodsForty seven healthy marathon runners (28 males and 19 females) who completed the 42.195 km of the 2016 Barcelona marathon were studied. Saliva and blood samples were collected the day before the marathon and two days after the end of the race. Salivary IgA, antimicrobial proteins (lactoferrin, lysozyme) and chemokines (Groα, Groβ, MCP-1) were determined using ELISA kits in saliva supernatant. Blood biochemistry and haemogram were analyzed in all participants. The presence of LRTI was considered in those runners who reported infectious lower respiratory tract symptoms during a minimum of 3 consecutive days in the 2 weeks after the race.

resultsEight participants (17%) presented a LRTI during the 2 weeks of follow-up. Higher lysozyme levels were detected after the race in runners with LRTI when compared with those without infection. A decrease in salivary lysozyme, Groα and Groβ levels after the race were observed in those runners who did not develop a LRTI when compared to basal levels. Salivary Groα levels correlated with basophil blood counts, and salivary lysozyme levels correlated with leukocyte blood counts.

conclusionsLRTI are common after a marathon race in non-elite healthy runners. Changes in salivary antimicrobial proteins and chemokines are related to the presence of LRTI and correlate with systemic defense cells, which suggest an important role of salivary immunity in the development of LRTI in non-elite marathon runners.

Indexed as

AdultChemokinesFemaleHumansImmunoglobulin ALactoferrinMaleMuramidaseRespiratory Tract InfectionsRunningSalivaChemokinesImmunoglobulin ALactoferrinMuramidase

Identifiers

PMID30462646
PMCPMC6248899
OpenAlexW2901667202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.